@inbook{7d52feacceaf444a95f928276c6c0121,
title = "Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice",
abstract = "The detection of neural antibodies in patients with paraneoplastic and autoimmune encephalitis has majorly advanced the diagnosis and management of neural antibody-associated diseases. Although testing for these antibodies has historically been restricted to specialized centers, assay commercialization has made this testing available to clinical chemistry laboratories worldwide. This improved test accessibility has led to reduced turnaround time and expedited diagnosis, which are beneficial to patient care. However, as the utilization of these assays has increased, so too has the need to evaluate how they perform in the clinical setting. In this chapter, we discuss assays for neural antibody detection that are in routine use, draw attention to their limitations and provide strategies to help clinicians and laboratorians overcome them, all with the aim of optimizing neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice.",
keywords = "Assay, Blot, False negative, False positive, Immunohistochemistry, Phenotype creep, Predictive value, Sensitivity, Specificity, Tissue indirect immunofluorescence",
author = "Adrian Budhram and Flanagan, {Eoin P.}",
note = "Publisher Copyright: {\textcopyright} 2024 Elsevier B.V.",
year = "2024",
month = jan,
doi = "10.1016/B978-0-12-823912-4.00002-5",
language = "English (US)",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier B.V.",
pages = "365--382",
booktitle = "Handbook of Clinical Neurology",
}